MOB015B-III
Laufzeit: 01.01.2018 - 31.12.2018
imported
Kurzfassung
A multi-centre, randomized, two-armed, parallel group
and evaluator-blinded study of efficacy and safety of
topical MOB015B in the treatment of mild to moderate
distal subungual onychomycosis (DSO)